Mar 11, 2013 7:56am EDT TONIX Completes Pre-Phase 3 Meeting With U.S. Food and Drug Administration for TNX-102 SL in Fibromyalgia
Mar 8, 2013 7:55am EST Tonix Pharmaceuticals to Present at the SeeThruEquity MicroCap Investor Forum on March 12
Dec 27, 2012 8:00am EST Tonix Pharmaceuticals Completes $1 Million Financing With Technology Partners
Nov 13, 2012 8:00am EST Tonix Pharmaceuticals Presents Research Findings at the 2012 American College of Rheumatology Annual Scientific Meeting
